Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients (Q39820086)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Makio Nagano

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Kei Fukami

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sho-Ichi Yamagishi

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Kazuko Sakai

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yusuke Kaida

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Takafumi Matsumoto

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Takuma Hazama

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Masahiro Tanaka

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Seiji Ueda

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Seiya Okuda

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

299-303

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Atherosclerosis in hemodialysis patients--the role of microinflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Carotid haemodynamic parameters as risk factors for cerebral infarction in Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

The impact of chronic inflammation on bone turnover in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2010.01419.X

21 January 2018

Identifiers

10.1111/J.1440-1797.2010.01419.X

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39820086&oldid=2165299089"